Institutional investors purchased a net $2.2 million shares of IBIO during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 9.33% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.2 Million shares of Ibio Inc
THE VANGUARD GROUP, INC. Bought 903.1 Thousand shares of Ibio Inc
GEODE CAPITAL MANAGEMENT LLC Bought 795.6 Thousand shares of Ibio Inc